G01N 2410/04
Oxytocins
Official title: Oxytocins; Vasopressins; Related peptides
G01N2410/04 (Oxytocins) appears on 7 US grants and 12 published applications in this corpus.
Search patents in G01N- Granted patents
- 7
- Published applications
- 12
- Assignees
- 7
- Inventors
- 22
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 2 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Oxytocin purifying method and measuring method and kit16 Jun 2026US 12,656,354 B2Fujifilm Wako Pure Chemical Corporation
- Method of obtaining a binder to prepro-vasopressin or fragments thereof23 Mar 2021US 10,954,298 B2B.R.A.H.M.S GmbH
- In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patient9 Apr 2019US 10,254,289 B2B.R.A.H.M.S GmbH
- Arginine vasopressin pro-hormone as predictive biomarker for diabetes24 Apr 2018US 9,952,229 B2B.R.A.H.M.S GmbH
- Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin II16 Feb 2016US 9,261,517 B2B.R.A.H.M.S GmbH
- Nanobiosensors and methods for detection and measurement using nanobiosensors14 May 2026US 2026/0133188 A1The Trustees of Columbia University in the City of New York
- Oxytocin purifying method and measuring method and kit11 Jul 2024US 2024/0230684 A9Fujifilm Wako Pure Chemical Corporation
- Oxytocin purifying method and measuring method and kit25 Apr 2024US 2024/0133901 A1Fujifilm Wako Pure Chemical Corporation
- Transistor type sensor11 May 2023US 2023/0148041 A1Jnc Corporation
- Biomarker for diagnosing autism spectrum disorder2 Sep 2021US 2021/0270851 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents